NPPB and hydrops fetalis: Although this method for analyzing NT-proBNP concentrations has been used in several other clinical trials on HF that assessed the interventional impact on NT-proBNP concentration as a surrogate endpoint of HF treatment [47, 48], it is still controversial whether measuring natriuretic peptides is sufficient to identify a clinically meaningful treatment effect [49, 50].